Ключевые слова: antibody, antigen, biological, biosimilar, biotech, biotechnology, blockade, cancer, checkpoint, combination, ctla4, cytotoxic, disease, drug, immune, immunoglobulin, immunology, immunooncology, immunotherapy, infusion, inhibitor, injection, inn, ipilumab, lymphocyte, lymphocyteassociated, mab, melanoma, monoclonal, neoantigen, nomenclature, oncology, peptide, protein, tumor,